BBP Among Health Care ETFs
End-of-day Nov 20, 2026 · 23 Health care ETFs by 10Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.5% | −7.4% | −9.1% | −11.6% | +18.3% | +24.2% | +92.6% | +86.2% | +173.9% | +268.3% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$56 of every $1,000 in BBP is Moderna
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MRNAModerna | Healthcare | 5.55% | $555.23 | 35K | $7.0M |
| 2 | XERSXeris Biopharma | Healthcare | 3.40% | $340.30 | 258K | $4.3M |
| 3 | KNSAKiniksa Pharmaceuticals International | Healthcare | 2.51% | $250.61 | 34K | $3.2M |
| 4 | IOVAIovance Biotherapeutics | Healthcare | 2.49% | $249.09 | 430K | $3.1M |
| 5 | VSTMVerastem | Healthcare | 2.33% | $232.61 | 428K | $2.9M |
| 6 | ADMAADMA Biologics | Healthcare | 2.26% | $225.90 | 214K | $2.8M |
| 7 | OMEROmeros | Healthcare | 2.23% | $222.98 | 201K | $2.8M |
| 8 | BGNEBeOne Medicines | — | 2.10% | $210.09 | 6,628 | $2.6M |
| 9 | REGNRegeneron Pharmaceuticals | Healthcare | 2.09% | $209.43 | 2,863 | $2.6M |
| 10 | INSMInsmed | Healthcare | 2.05% | $205.26 | 18K | $2.6M |
| 11 | HALOHalozyme Therapeutics | Healthcare | 1.86% | $186.12 | 25K | $2.3M |
| 12 | GILDGilead Sciences | Healthcare | 1.84% | $184.34 | 14K | $2.3M |
| 13 | RYTMRhythm Pharmaceuticals | Healthcare | 1.84% | $183.74 | 20K | $2.3M |
| 14 | TGTXTG Therapeutics | Healthcare | 1.82% | $182.15 | 35K | $2.3M |
| 15 | ROIVRoivant Sciences | Healthcare | 1.80% | $180.31 | 58K | $2.3M |
of the $108B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MRNA | Moderna | 5.55% |
| 2 | XERS | Xeris Biopharma | 3.40% |
| 3 | KNSA | Kiniksa Pharmaceuticals International | 2.51% |
| 4 | IOVA | Iovance Biotherapeutics | 2.49% |
| 5 | VSTM | Verastem | 2.33% |
| 6 | ADMA | ADMA Biologics | 2.26% |
| 7 | OMER | Omeros | 2.23% |
| 8 | BGNE | BeOne Medicines | 2.10% |
| 9 | REGN | Regeneron Pharmaceuticals | 2.09% |
| 10 | INSM | Insmed | 2.05% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 20, 2017 | Dec 27, 2017 | $0.0723 |
| Dec 21, 2015 | Dec 29, 2015 | $0.40 |